The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Plasma Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Plasma, pale yellow in color, is the component of the blood.
The global Plasma Therapeutics market size is expected to reach US$ 526.8 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Therapeutics in various end use industries. The expanding demands from the Research Laboratories And Institutions, Hospitals and Stand-Alone Blood Banks,, are propelling Plasma Therapeutics market. Human Serum Protein, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma-Derived Clotting Factor segment is estimated at % CAGR for the next seven-year period.
To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Therapeutics covered in this report include Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma and BioDelivery Sciences, etc.
The global Plasma Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
CSL Behring
Grifols Therapeutics
Octapharma
Abeona Therapeutics
ADMA Biologics
Amag Pharmaceuticals
Antares Pharma
BioDelivery Sciences
Bio Products Laboratory
Biota Pharmaceuticals
Biotest Pharmaceuticals
China Biologic Products
Global Plasma Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Therapeutics market, Segment by Type:
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins
Global Plasma Therapeutics market, by Application
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plasma Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Plasma, pale yellow in color, is the component of the blood.
The global Plasma Therapeutics market size is expected to reach US$ 526.8 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Therapeutics in various end use industries. The expanding demands from the Research Laboratories And Institutions, Hospitals and Stand-Alone Blood Banks,, are propelling Plasma Therapeutics market. Human Serum Protein, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma-Derived Clotting Factor segment is estimated at % CAGR for the next seven-year period.
To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Therapeutics covered in this report include Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma and BioDelivery Sciences, etc.
The global Plasma Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
CSL Behring
Grifols Therapeutics
Octapharma
Abeona Therapeutics
ADMA Biologics
Amag Pharmaceuticals
Antares Pharma
BioDelivery Sciences
Bio Products Laboratory
Biota Pharmaceuticals
Biotest Pharmaceuticals
China Biologic Products
Global Plasma Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Therapeutics market, Segment by Type:
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins
Global Plasma Therapeutics market, by Application
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plasma Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Plasma Therapeutics
1.1 Plasma Therapeutics Market Overview
1.1.1 Plasma Therapeutics Product Scope
1.1.2 Plasma Therapeutics Market Status and Outlook
1.2 Global Plasma Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Plasma Therapeutics Market Size by Region (2018-2029)
1.4 Global Plasma Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Plasma Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Plasma Therapeutics Market Size (2018-2029)
1.6.1 North America Plasma Therapeutics Market Size (2018-2029)
1.6.2 Europe Plasma Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Plasma Therapeutics Market Size (2018-2029)
1.6.4 Latin America Plasma Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Plasma Therapeutics Market Size (2018-2029)
2 Plasma Therapeutics Market by Type
2.1 Introduction
2.1.1 Human Serum Protein
2.1.2 Plasma-Derived Clotting Factor
2.1.3 Immunoglobulins
2.1.4 High Immunoglobulins
2.2 Global Plasma Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Plasma Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Plasma Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
3 Plasma Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Research Laboratories And Institutions
3.1.2 Hospitals
3.1.3 Stand-Alone Blood Banks
3.2 Global Plasma Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Plasma Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Plasma Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
4 Plasma Therapeutics Competition Analysis by Players
4.1 Global Plasma Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Therapeutics as of 2022)
4.3 Date of Key Players Enter into Plasma Therapeutics Market
4.4 Global Top Players Plasma Therapeutics Headquarters and Area Served
4.5 Key Players Plasma Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Plasma Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Baxter
5.1.1 Baxter Profile
5.1.2 Baxter Main Business
5.1.3 Baxter Plasma Therapeutics Products, Services and Solutions
5.1.4 Baxter Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Baxter Recent Developments
5.2 CSL Behring
5.2.1 CSL Behring Profile
5.2.2 CSL Behring Main Business
5.2.3 CSL Behring Plasma Therapeutics Products, Services and Solutions
5.2.4 CSL Behring Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 CSL Behring Recent Developments
5.3 Grifols Therapeutics
5.3.1 Grifols Therapeutics Profile
5.3.2 Grifols Therapeutics Main Business
5.3.3 Grifols Therapeutics Plasma Therapeutics Products, Services and Solutions
5.3.4 Grifols Therapeutics Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Octapharma Recent Developments
5.4 Octapharma
5.4.1 Octapharma Profile
5.4.2 Octapharma Main Business
5.4.3 Octapharma Plasma Therapeutics Products, Services and Solutions
5.4.4 Octapharma Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Octapharma Recent Developments
5.5 Abeona Therapeutics
5.5.1 Abeona Therapeutics Profile
5.5.2 Abeona Therapeutics Main Business
5.5.3 Abeona Therapeutics Plasma Therapeutics Products, Services and Solutions
5.5.4 Abeona Therapeutics Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Abeona Therapeutics Recent Developments
5.6 ADMA Biologics
5.6.1 ADMA Biologics Profile
5.6.2 ADMA Biologics Main Business
5.6.3 ADMA Biologics Plasma Therapeutics Products, Services and Solutions
5.6.4 ADMA Biologics Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 ADMA Biologics Recent Developments
5.7 Amag Pharmaceuticals
5.7.1 Amag Pharmaceuticals Profile
5.7.2 Amag Pharmaceuticals Main Business
5.7.3 Amag Pharmaceuticals Plasma Therapeutics Products, Services and Solutions
5.7.4 Amag Pharmaceuticals Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Amag Pharmaceuticals Recent Developments
5.8 Antares Pharma
5.8.1 Antares Pharma Profile
5.8.2 Antares Pharma Main Business
5.8.3 Antares Pharma Plasma Therapeutics Products, Services and Solutions
5.8.4 Antares Pharma Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Antares Pharma Recent Developments
5.9 BioDelivery Sciences
5.9.1 BioDelivery Sciences Profile
5.9.2 BioDelivery Sciences Main Business
5.9.3 BioDelivery Sciences Plasma Therapeutics Products, Services and Solutions
5.9.4 BioDelivery Sciences Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 BioDelivery Sciences Recent Developments
5.10 Bio Products Laboratory
5.10.1 Bio Products Laboratory Profile
5.10.2 Bio Products Laboratory Main Business
5.10.3 Bio Products Laboratory Plasma Therapeutics Products, Services and Solutions
5.10.4 Bio Products Laboratory Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Bio Products Laboratory Recent Developments
5.11 Biota Pharmaceuticals
5.11.1 Biota Pharmaceuticals Profile
5.11.2 Biota Pharmaceuticals Main Business
5.11.3 Biota Pharmaceuticals Plasma Therapeutics Products, Services and Solutions
5.11.4 Biota Pharmaceuticals Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Biota Pharmaceuticals Recent Developments
5.12 Biotest Pharmaceuticals
5.12.1 Biotest Pharmaceuticals Profile
5.12.2 Biotest Pharmaceuticals Main Business
5.12.3 Biotest Pharmaceuticals Plasma Therapeutics Products, Services and Solutions
5.12.4 Biotest Pharmaceuticals Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Biotest Pharmaceuticals Recent Developments
5.13 China Biologic Products
5.13.1 China Biologic Products Profile
5.13.2 China Biologic Products Main Business
5.13.3 China Biologic Products Plasma Therapeutics Products, Services and Solutions
5.13.4 China Biologic Products Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 China Biologic Products Recent Developments
6 North America
6.1 North America Plasma Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Plasma Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Plasma Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Plasma Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Plasma Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Plasma Therapeutics Market Dynamics
11.1 Plasma Therapeutics Industry Trends
11.2 Plasma Therapeutics Market Drivers
11.3 Plasma Therapeutics Market Challenges
11.4 Plasma Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
